Elite Pharmaceuticals
ELTP · OTC
$0.2452−$0.0055 (−2.19%)TodayMarket closed ·
Prev close $0.2507
Who owns ELTP
Largest institutional holders, from their latest 13F filings
The 8 largest institutions hold 22.4% of ELTP’s shares.
- Hakim (Nasrat A)20.6%
- Plassche (Douglas)0.6%
- Ward (Carter Julian CPA)0.5%
- Dash (Barry H)0.3%
- Next 4 largest institutions0.5%
- All other shareholders77.6%
| Holder | Shares | % of shares |
|---|---|---|
| Hakim (Nasrat A) | 221.57M | 20.57% |
| Plassche (Douglas) | 6.00M | 0.56% |
| Ward (Carter Julian CPA) | 4.99M | 0.46% |
| Dash (Barry H) | 3.24M | 0.30% |
| Whitnell (Jeffrey A) | 3.19M | 0.30% |
| Caskey (Davis S) | 2.05M | 0.19% |
| Kirkov (Kirko) | 16.37K | 0.00% |
| Kelleher Financial Advisors, LLC | 1.00K | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $8.61K (1 trade) of ELTP on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Dash Barry H | Buy | 30.00K | $8.61K |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.63M
- Days to cover
- 2.24
- % of shares outstanding
- 0.24%
- Average daily volume
- 1.18M
- Change since last report
- +1.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.